Why do sclerosis patients fall ill from medicine, which works well for patients with conditions such as psoriasis, arthritis and inflammatory bowel disease?
An international group of researchers headed by Lars Fugger, professor at University of Aarhus and Aarhus University Hospital, has found the answer to that question in a new study, the results of which have just been published in the medical journal Nature.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app